Project Grant R01HL177812
Award Date
9/9/24
Completion Date
5/31/27
Dollars Obligated
$206K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Indiana, USA
Similar Awards
This federal Project Grant award of $863,328 was provided by the National Heart Lung and Blood Institute (NHLBI) under the Cardiovascular Diseases Research Program (CFDA 93.837) to Aquillius Corp, a certified economically disadvantaged women-owned small business. The grant supports the development of a wearable graphene-based respiratory sensor for early detection and continuous monitoring of asthma, particularly in children. The key objectives are to: (1) optimize the sensor's function using...
This $2,623,234 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports the development of a wearable multiplex biosensor system to monitor exacerbation risk in patients with chronic obstructive pulmonary disease (COPD). The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center is the prime awardee, collaborating with researchers at the California Institute of Technology...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $269,922 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Steth X Microsystems Inc. to develop a smart, wearable contact microphone patch for extended and remote monitoring of lung functions. The goal is to create a low-profile, battery-powered wireless device capable of accurately detecting and quantifying adventitious lung sounds as well as breathing abnormalities in patients with respiratory...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research Federal Grant Program (CFDA 93.837), provides $1,052,276 to Lasarrus Clinic And Research Center Inc. to develop a novel mobile health system for remote monitoring of patients with chronic obstructive pulmonary disease (COPD). The project aims to leverage a wearable multimodal sensor, called the WearMe system, to continuously monitor physiological biomarkers and lung...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $117,750 Project Grant (CFDA 93.837 Cardiovascular Diseases Research) to the Ann & Robert H. Lurie Children's Hospital of Chicago to validate the use of wireless biosensors and a portable capnograph for remote patient monitoring of children with invasive home mechanical ventilation (IHMV). The project aims to address key limitations in the hospital's existing remote monitoring dashboard, including the time and cognitive burden...
This federal Project Grant award, valued at $807,067.00 and issued by the National Heart Lung and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), aims to advance the understanding and quantification of respiratory kinematics as novel physiological markers for predicting respiratory failure. The key objectives of this five-year project are to: Pioneer the quantitative documentation of the human respiratory kinematic profile in a large cohort of adults...
The National Institute of Environmental Health Sciences (NIEHS) awarded Canairy LLC a Project Grant under the Environmental Health (CFDA 93.113) federal grant program. The $324,770 award, which runs from September 2024 to September 2025, supports the development of a stand-alone wearable device to track environmental exposures and assess respiratory functions for patients with chronic obstructive pulmonary disease (COPD). The device will collect data on personal exposure to pollutants and...
The federal Project Grant award R43HL172316, for $604,750, was provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research (CFDA 93.837) program. The funding supports the development of a novel inhalation device prototype for the pulmonary delivery of anti-inflammatory agents to the distal airways of patients with chronic obstructive pulmonary disease (COPD). The device leverages a "bottom-up" aerosolization technology to generate...
This federal Project Grant award of $2,000,987.00 from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) supports research to examine how the antiviral immune response and associated metabolic changes in the respiratory epithelium can promote the growth of Pseudomonas aeruginosa biofilms during viral-bacterial co-infections in cystic fibrosis patients. The research, led by the Trustees of Dartmouth College, aims to elucidate the molecular mechanisms...
This Project Grant award from the National Heart Lung and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) aims to develop a modern Electrical Impedance Tomography (EIT) device for monitoring children in the Intensive Care Unit (ICU). The $299,900 award to Goodlife Inventors LLC will fund efforts to (1) generate initial designs for an advanced lightweight EIT belt and (2) assess the technical feasibility of a miniaturized, easier to use EIT core device. If...